Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3
Condition:   Achromatopsia Intervention:   Biological: AAV - CNGB3 Sponsors:   MeiraGTx UK II Ltd;   Syne Qua Non Limited;   Emas Pharma Ltd. Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2017 Category: Research Source Type: clinical trials